Craig-Hallum Remains a Buy on Phathom Pharmaceuticals (PHAT)
Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), ACELYRIN, INC. (SLRN) and Moderna (MRNA)
Phathom Pharmaceuticals Analyst Ratings
Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $26 Price Target
Phathom Pharmaceuticals Analyst Ratings
Buy Rating Affirmed for Phathom Pharmaceuticals on V Oquezna's Promising Market Trajectory
Phathom Pharmaceuticals Analyst Ratings
Phathom Pharmaceuticals Analyst Ratings
Buy Rating Justified by Strong Market Acceptance of Phathom Pharmaceuticals' V Oquezna
Phathom Pharmaceuticals Analyst Ratings
Buy Rating Affirmed for Phathom Pharmaceuticals Amid Strong Uptake of V Oquezna
Phathom Pharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Rallybio (RLYB), Phathom Pharmaceuticals (PHAT) and Amylyx Pharmaceuticals Inc (AMLX)
Phathom Pharmaceuticals Analyst Ratings
Phathom Pharmaceuticals Analyst Ratings
Phathom Pharmaceuticals Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Phathom Pharmaceuticals (PHAT)
Phathom Pharmaceuticals Analyst Ratings
Positive Prescription Trends and Resilience Prompt Buy Rating for Phathom Pharmaceuticals
Phathom Pharmaceuticals Analyst Ratings
No Data